Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianlin Yang

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Bone|March 29, 2011
Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine modelWei Zhang, Steven D Rhodes, Liming Zhao, et al.
Plos One|March 19, 2015
Dystrophic spinal deformities in a neurofibromatosis type 1 murine modelSteven D Rhodes, Wei Zhang, Dalong Yang, et al.
Human Molecular Genetics|July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient miceRicha Sharma, Xiaohua Wu, Steven D Rhodes, et al.
Pediatric Blood & Cancer|September 17, 2015
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform NeurofibromasMichael J Ferguson, Steven D Rhodes, Li Jiang, et al.
Blood|November 21, 2013
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in miceJiapeng Wang, Zhaomin Li, Yongzheng He, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 2015
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal HomeostasisSteven D Rhodes, Hao Yang, Ruizhi Dong, et al.
Stem Cells (Dayton, Ohio)|January 15, 2015
Pak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiationYi Zeng, Hal E Broxmeyer, Karl Staser, et al.
Plos One|October 8, 2011
The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1Xiaohua Wu, Shi Chen, Yongzheng He, et al.
Pediatric Blood & Cancer|May 28, 2020
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1Amy E Armstrong, Steven D Rhodes, Abbi Smith, et al.
The Journal of Cell Biology|June 19, 2013
The tumor suppressor CDKN3 controls mitosisGrzegorz Nalepa, Jill Barnholtz-Sloan, Rikki Enzor, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bone|March 29, 2011
Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine modelWei Zhang, Steven D Rhodes, Liming Zhao, et al.
Plos One|March 19, 2015
Dystrophic spinal deformities in a neurofibromatosis type 1 murine modelSteven D Rhodes, Wei Zhang, Dalong Yang, et al.
Human Molecular Genetics|July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient miceRicha Sharma, Xiaohua Wu, Steven D Rhodes, et al.
Pediatric Blood & Cancer|September 17, 2015
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform NeurofibromasMichael J Ferguson, Steven D Rhodes, Li Jiang, et al.
Blood|November 21, 2013
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in miceJiapeng Wang, Zhaomin Li, Yongzheng He, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 2015
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal HomeostasisSteven D Rhodes, Hao Yang, Ruizhi Dong, et al.
Stem Cells (Dayton, Ohio)|January 15, 2015
Pak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiationYi Zeng, Hal E Broxmeyer, Karl Staser, et al.
Plos One|October 8, 2011
The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1Xiaohua Wu, Shi Chen, Yongzheng He, et al.
Pediatric Blood & Cancer|May 28, 2020
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1Amy E Armstrong, Steven D Rhodes, Abbi Smith, et al.
The Journal of Cell Biology|June 19, 2013
The tumor suppressor CDKN3 controls mitosisGrzegorz Nalepa, Jill Barnholtz-Sloan, Rikki Enzor, et al.
Pageof 3